You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Role of B7-H4 in Tumor Vaccine

Recruiting
  • Glioma
  • tumor vaccine
  • Shanghai, Shanghai, China
    Di Chen
Nov 26, 2023

RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)

Recruiting
  • Cervical
    • Wuxi, Jiangsu, China
      Wuxi People's Hospital
    Jul 3, 2023

    Solid Tumor, Adult Trial in Beijing (Vaccine)

    Not yet recruiting
    • Solid Tumor, Adult
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Aug 3, 2023

    Tumor Vaccines for Solid Tumors

    Recruiting
    • Glioma
    • Solid Tumor
    • tumor vaccine
    • +3 more
    • Shanghai, Shanghai, China
      Huashan Hospital, Fudan University
    Oct 22, 2023

    Tumor Vaccine Benefit for Gliomas

    Recruiting
    • Glioma
    • DC vaccine
    • Shanghai, China
      Huashan Hospital，Fudan University
    Sep 12, 2023

    Solid Tumor Trial in Adelaide (Radvax)

    Recruiting
    • Solid Tumor
    • Radvax
    • Adelaide, South Australia, Australia
      ARASMI
    Apr 8, 2023

    Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

    Recruiting
    • Advanced Solid Tumor
    • Personalized neoantigen tumor vaccine
    • Shanghai, Shanghai, China
      Ruijin Hospital Shanghai Jiaotong University School of Medicine
    Jun 24, 2023

    Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

    Recruiting
    • Advanced Pancreatic Cancer
    • Personalized neoantigen tumor vaccine
    • Qionghai, Hainan, China
      Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
    Jun 14, 2023

    Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

    Not yet recruiting
    • Posto Perative Hepatocellular Carcinoma
    • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
    • (no location specified)
    Feb 27, 2023

    Advanced Solid Tumor Trial in Bengbu (RNA tumor vaccine, RNA tumor vaccine+Navuliumab)

    Recruiting
    • Advanced Solid Tumor
    • RNA tumor vaccine
    • RNA tumor vaccine+Navuliumab
    • Bengbu, Anhui, China
      First Affiliated Hospital Bengbu Medical College
    Mar 21, 2022

    Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach Trial in Bengbu (HER2 Tumor Vaccine, HER2 Tumor Vaccine+ Standard of Care

    Recruiting
    • Adenocarcinoma - GEJ
    • Adenocarcinoma of the Stomach
    • HER2 Tumor Vaccine
    • HER2 Tumor Vaccine+ Standard of Care chemotherapy
    • Bengbu, Anhui, China
      First Affiliated Hospital Bengbu Medical College
    Apr 6, 2022

    Solid Tumors, Adult Trial (tumor treatment vaccine injection)

    Not yet recruiting
    • Solid Tumors, Adult
    • tumor treatment vaccine injection
    • (no location specified)
    Feb 16, 2023

    Solid Tumor Trial in Beijing (Personalized neoantigen tumor vaccine)

    Not yet recruiting
    • Solid Tumor
    • Personalized neoantigen tumor vaccine
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 28, 2022

    Gastric Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

    Not yet recruiting
    • Gastric Cancer
    • neoantigen tumor vaccine with or without PD-1/L1
    • Beijing, China
      Department of GI Oncology, Peking University Cancer Hospital,
    Jan 26, 2022

    Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

    Not yet recruiting
    • Adrenal Cortical Carcinoma
    • +3 more
    • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
    Nov 19, 2023

    Follicular Lymphoma Trial in Saint Louis (biological, drug, procedure)

    Suspended
    • Follicular Lymphoma
    • Personalized tumor vaccine
    • +6 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 9, 2021

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

    Not yet recruiting
    • Glioma, Malignant
    • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
    • Hiltonol
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University
    Jan 19, 2023

    Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Giant Cell Glioblastoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Jan 4, 2023

    Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

    Recruiting
    • Lynch Syndrome
    • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
    • +2 more
    • Duarte, California
    • +3 more
    Nov 22, 2022

    Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

    Not yet recruiting
    • Low Grade Glioma of Brain
    • PEPIDH1M vaccine + vorasidenib
    • Durham, North Carolina
      Duke University Medical Center
    Nov 2, 2022

    Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

    Not yet recruiting
    • Advanced Malignant Solid Tumors
    • Neoantigen peptide vaccine
    • Neoantigen-based DC immune preparation
    • Nanchang, Jiangxi, China
      First Affiliated Hospital of Nanchang University
    Mar 1, 2023

    Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

    Recruiting
    • Gastric Cancer
    • +2 more
    • neoantigen tumor vaccine with or without PD-1/L1
    • Beijing, Beijing, China
      PLA General Hospital
    Jan 27, 2022

    Solid Tumor Trial in Shanghai (DC cells)

    Recruiting
    • Solid Tumor
    • DC cells
    • Shanghai, Shanghai, China
      Shanghai Mengchao Cancer Hospital
    Aug 23, 2023

    Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

    Active, not recruiting
    Has Results
    • Renal Cancer
    • Dendritic Cell Tumor Fusion Vaccine
    • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 2, 2023